Results of a clinical trial of g‐28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects
Open Access
- 1 December 1958
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 1 (6) , 532-543
- https://doi.org/10.1002/art.1780010606
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- ZoxazolamineThe American Journal of Medicine, 1958
- Zoxazolamine — A Potent Uricosuric AgentNew England Journal of Medicine, 1958
- PROTRACTED URICOSURIC THERAPY IN TOPHACEOUS GOUT*1The Lancet, 1957
- Evaluation of Uricosuric Agents in Chronic GoutAnnals of the Rheumatic Diseases, 1957
- A POTENT NEW URICOSURIC AGENT, THE SULFOXIDE METABOLITE OF THE PHENYLBUTAZONE ANALOGUE, G-256711957
- EFFECT OF A PHENYLBUTAZONE ANALOG (4-[PHENYLTHIOETHYL]-1,2-DIPHENYL 3,5-PYRAZOLIDINEDIONE) ON URATE CLEARANCE AND OTHER DISCRETE RENAL FUNCTIONS IN GOUTY SUBJECTS. EVALUATION AS URICOSURIC AGENT 1Journal of Clinical Investigation, 1956
- New York Rheumatism AssociationAnnals of the Rheumatic Diseases, 1955
- Observations on G-25671, A Phenylbutazone Analogue (4-(phenylthioethyl) -1,2-diphenyl 3,5-pyrazolidinedione).Experimental Biology and Medicine, 1954
- EFFECT OF BENEMID (p-[di-n-PROPYLSULFAMYL]-BENZOIC ACID) ON URATE CLEARANCE AND OTHER DISCRETE RENAL FUNCTIONS IN GOUTY SUBJECTS 1Journal of Clinical Investigation, 1952
- Mobilization of gouty tophi by protracted use of uricosuric agentsThe American Journal of Medicine, 1951